NRX Therapeutics(NRXP.US)

Last Updated 19:00:00 ET
longbridge loading

NRx Pharmaceuticals (Nasdaq:NRXP) notes presentation by Osmind, Inc. of IV Ketamine Efficacy vs. Nasal esketamine Efficacy at American Society of Clinical Psychopharmacology. | NRXP Stock News

StockTitan·
US
NRXP
-2.04%
StockTitan·
US
NRXP
-2.04%

NRx Pharmaceuticals Prices $3.50 Stock Offering to Raise ~$18.8 Million; BTIG Leads

TradingView·
US
NRXP
-2.04%
TradingView·
US
NRXP
-2.04%

NRx Pharmaceuticals, Inc. Announces Closing of $22.3 Million Public Offering of Common Stock and Including Exercise of the Underwriters’ Option | NRXP Stock News

StockTitan·
US
NRXP
-2.04%
StockTitan·
US
NRXP
-2.04%

NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock | NRXP Stock News

StockTitan·
US
NRXP
-2.04%
StockTitan·
US
NRXP
-2.04%

At a glance: Stocks gapping down premarket

MSN·
US
NRXP
-2.04%
US
YEXT
+7.41%
US
TTI
-0.48%
MSN·
US
NRXP
-2.04%
US
YEXT
+7.41%
US
TTI
-0.48%

Why Tetra Technologies Shares Are Trading Lower By Over 15%; Here Are 20 Stocks Moving Premarket

benzinga_article·
US
JZ
-11.30%
US
SOAR
-1.75%
US
XOS
-18.03%
benzinga_article·
US
JZ
-11.30%
US
SOAR
-1.75%
US
XOS
-18.03%
© 2026 Longbridge｜Disclaimer